Vallon Pharmaceuticals Inc

NASDAQ:VLON   3:59:53 PM EDT
4.98
-0.40 (-7.36%)
Earnings Announcements

Vallon Pharmaceuticals Reports Qtrly Net Loss Of $1.3 Mln

Published: 11/12/2021 13:25 GMT
Vallon Pharmaceuticals Inc (VLON) - Vallon Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update.
Vallon Pharmaceuticals Inc - Net Loss for Quarter Ended September 30, 2021, Was $1.3 Million.
Vallon Pharmaceuticals - Expects Cash, Cash Equivalents Will Provide Funding for Its Ongoing Development and Business Activities Into Q3 of 2022.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.22

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.22

More details on our Analysts Page.